Clin2
NCT06989840Possibly a fitRecruiting

Safety study of TVB-3567 for acne

Acne

Part of Skin clinical trials.

This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
128 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are 18 to 55 years old.
  • Your weight is within a healthy range (BMI between 18 and 37 for people with acne, or 18 to 32 for others).
  • You are generally healthy, with no serious medical or mental health issues.
  • If you have acne, it must be moderate to severe (doesn't include mild breakouts).
  • You haven't used certain acne medications like tretinoin or isotretinoin recently.
  • You are not pregnant or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06316297Recruiting· Phase 1/Phase 2
Testing a new mRNA vaccine for moderate to severe acne

This study tests an experimental mRNA vaccine designed to help the immune system fight acne-causing bacteria. It's for adults with moderate or severe facial acne who are otherwise healthy, and it may offer a new way to treat acne beyond typical creams or pills.

Scottsdale, Arizona
NCT06716398Recruiting
A cosmetic study for teens and young adults with acne

This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.

São Paulo
NCT07010458Not yet recruiting
Acne treatments through clinical research

This study tests different acne treatments to see how well they work. It may help you manage your acne with a new option.

San Francisco, California
NCT07411638Not yet recruiting
Acne skin and blood study for ages 18 to 25

This study looks at skin swabs and blood samples from people with different levels of acne to better understand the condition. You won't receive any new treatment, but you'll help researchers learn more about acne.

NCT07013747Recruiting· Phase 1/Phase 2
Acne mRNA vaccine for mild acne

This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.

Encino, California
NCT06625177Recruiting· Phase 1
Study of a new medicine for vitiligo

This trial tests a new medicine called TEV-53408 to see if it can help with vitiligo, a condition that causes white patches on the skin. It may help by restoring skin color, and the study will check how safe and effective it is.

Scottsdale, Arizona

Hear when a new Acne trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.